Abbott to Pay $1.67B in Patent Suit
J&J emerged victorious in a patent suit claiming that the technology behind Abbott's blockbuster arthritis treatment Humira is too similar in design to J&J's Remicade. The cost to Abbott: $1.67 Billion.
A risk-based approach to records and information management can be an integral part of the effort to reduce costs stemming from litigation.
2 Commerce Drive Cranbury, NJ 08512